1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Vascular and Non-Vascular Stents Global Market – Forecast To 2021

Vascular and Non-Vascular Stents Global Market – Forecast To 2021

  • October 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 349 pages

Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation Stents helps in improvement of the blood flow and prevents the blood vessels from bursting The global stents market is segmented based on the types, applications, materials, coatings, and geography Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents By applications, the stents are divided into two segments as vascular and non-vascular stents Vascular stents are further classified into coronary stents and peripheral stents Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents

Neurovascular stents sub segmented into carotid stents and intracranial stents Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents Urology stents are further segmented into ureteral & urethral stents and prostate stents Depending on its materials, there are Metals and Polymers

Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers Based on the coating, there are coated stents and non-coated stents Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents Polymer coated stents subdivided into non-biodegradable polymer and bio-degradable polymer coated stents Geographical wise stents market segmented into North America, Europe, Asia-Pacific and Rest of the world (RoW)

Among the stents by type, drug-eluting stents occupied the largest share in 2014 and bio-resorbable stent segment is the fastest growing segment from 2014 to 2021 Based on applications, vascular stents hold the major share in 2014 and which is again the fastest growing segment at mid single digit CAGR from 2014 to 2021 Based on materials, metals occupied the largest share of 90,3% in 2014 and polymers segment is the fastest growing segment from 2014 to 2021 In case of coatings, coated stents occupied the largest share in 2014 and which is also expected to grow at high single digit CAGR offrom 2014 to 2021

Similarly by geographies, North America holds the major share of 42,3% among the geographies due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia is the fastest growing segment from 2014 to 2021 due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market

The stents market is expected to grow steadily from 2014 to 2021 The factors driving the growth of this market are increasing incidence of metabolic diseases, advancement in technology, raising old age population, preference for minimally invasive solution and rise in vascular procedures In addition to this, improving modalities of stent placements, stent adaptation in emerging regions, wide usage of stents and improvement in stent design and customized stents are some of the opportunities that are propelling the growth of the market However, slashing prices of stents, side effects associated with stents and less adoption and long term efficacy of novel technologies are hampering the growth of the market The threats for the stents market include reduced reimbursement, alternative procedures and stringent regulations for stent approval and medical tax

The global stents market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares Some of the key players of the stents market are Abbott laboratories (US), BBraun (Germany), Biosensors (Singapore), Boston scientific (US), Cordis Corporation (US), Medtronic (Ireland), Olympus (Japan), Microport (China), Terumo (Japan), Biotronik (Germany) Cook Medical (US) and CRBard (US)

Table Of Contents

Vascular and Non-Vascular Stents Global Market - Forecast To 2021

1 EXECUTIVE SUMMARY 22
2 INTRODUCTION 29
2.1 KEY TAKE AWAYS 29
2.2 REPORT DESCRIPTION 29
2.3 MARKETS COVERED 31
2.4 STAKEHOLDERS 33
2.5 RESEARCH METHODOLOGY 33
2.5.1 MARKET SIZE ESTIMATION 35
2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 37
2.5.3 SECONDARY SOURCES 38
2.5.4 PRIMARY SOURCES 39
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 39
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 40
2.5.7 ASSUMPTIONS 40
3 MARKET ANALYSIS 42
3.1 INTRODUCTION 42
3.2 MARKET SEGMENTATION 43
3.3 FACTORS INFLUENCING MARKET 46
3.3.1 DRIVERS AND OPPORTUNITIES 46
3.3.1.1 Increasing incidence of metabolic diseases 46
3.3.1.2 Advancement in technology 47
3.3.1.3 Rising old age population 48
3.3.1.4 Preference for minimally-invasive solutions and rise in vascular procedures....................................................................................48
3.3.1.5 Improving modalities for stent placements 49
3.3.1.6 Stent adoption in emerging regions 49
3.3.1.7 Wide usage of stents 50
3.3.1.8 Improvements in stent designing 50
3.3.2 RESTRAINTS AND THREATS 51
3.3.2.1 Slashing stent prices 51
3.3.2.2 Side effects associated with stents 51
3.3.2.3 Less adoption and long term efficacy of novel technologies 52
3.3.2.4 Reduced reimbursements 52
3.3.2.5 Alternative procedures 52
3.3.2.6 Stringent regulations 53
3.4 PORTER'S FIVE FORCE ANALYSIS 53
3.4.1 THREAT OF NEW ENTRANTS 53
3.4.2 THREAT OF SUBSTITUTES 54
3.4.3 BARGAINING POWER OF SUPPLIERS 55
3.4.4 BARGAINING POWER OF BUYERS 56
3.4.5 COMPETITIVE RIVALRY 56
3.5 REGULATORY AFFAIRS 56
3.5.1 U.S. 57
3.5.2 EUROPE 57
3.5.3 INDIA 57
3.5.4 CHINA 58
3.5.5 JAPAN 58
3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 60
3.7 REIMBURSEMENT SCENARIO 62
3.7.1 CORONARY INTERVENTIONS 62
3.7.2 CAROTID ARTERY STENTING 63
3.7.3 PERIPHERAL INTERVENTIONS 64
3.7.4 BILIARY STENTING 66
3.7.5 ESOPHAGEAL STENTING 67
3.7.6 COLONIC AND DUODENAL STENTING 68
3.7.7 TRACHEOBRONCHIAL STENTING 69
3.7.8 URETERAL STENTING 69
3.7.9 EYE STENT 70
3.8 UPCOMING TECHNOLOGIES 70
3.9 SUPPLY CHAIN ANALYSIS 83
3.10 PATENT ANALYSIS 84
4 STENTS MARKET, BY TYPES 87
4.1 INTRODUCTION 87
4.2 BARE METAL STENTS 90
4.3 DRUG ELUTING STENTS 93
4.4 BIO-RESORBABLE STENTS (BIO-ABSORBABLE STENTS and BIO-DEGRADABLE STENTS) 96
4.5 OTHERS STENTS 100
5 STENTS MARKET, BY APPLICATION 102
5.1 INTRODUCTION 102
5.2 VASCULAR STENTS 104
5.2.1 CORONARY STENTS 107
5.2.2 PERIPHERAL STENTS 110
5.2.2.1 Lower extremity and iliac stents 112
5.2.2.2 Neurovascular stents 114
5.2.2.2.1 Carotid stents...................................................................................... 116
5.2.2.2.2 Intracranial stents ............................................................................... 118
5.2.2.3 Renal artery stents 120
5.3 NON-VASCULAR STENTS 121
5.3.1 GASTROINTESTINAL STENTS 125
5.3.1.1 Pancreatic and biliary stents 127
5.3.1.2 Esophageal stents 129
5.3.1.3 Colorectal stents 131
5.3.1.4 Duodenal stents 132
5.3.2 AIRWAY STENTS 134
5.3.3 UROLOGY STENTS 135
5.3.3.1 Ureteral stents and urethral stents 137
5.3.3.2 Prostate stents 140
5.3.4 OPHTHALMOLOGY and OTHER STENTS 141
6 STENTS MARKET, BY MATERIALS 144
6.1 INTRODUCTION 144
6.2 METAL STENTS 146
6.2.1 COBALT-CHROMIUM STENTS 149
6.2.2 NICKEL-TITANIUM STENTS 151
6.2.3 PLATINUM-CHROMIUM STENTS 152
6.2.4 STAINLESS STEEL STENTS 154
6.2.5 OTHERS 155
6.3 POLYMERS STENTS 156
6.3.1 DURABLE POLYMERS STENTS 160
6.3.2 BIO-ABSORBABLE POLYMER STENTS 161
7 STENTS MARKET, BY COATINGS 164
7.1 INTRODUCTION 164
7.2 NON-COATED STENTS 166
7.3 COATED STENTS 168
7.3.1 INORGANIC COATINGS 171
7.3.2 POLYMER COATED STENTS 173
7.3.2.1 Non-biodegradable polymer coated stents 174
7.3.2.2 Bio-degradable polymer coated stents 177
7.3.3 POLYMER-FREE COATED STENTS 179
7.3.4 OTHER COATED STENTS 181
8 REGIONAL MARKET ANALYSIS 184
8.1 INTRODUCTION 184
8.2 NORTH AMERICA 186
8.3 EUROPE 197
8.4 ASIA PACIFIC 208
8.5 REST OF THE WORLD (ROW) 220
9 COMPANY DEVELOPMENTS 233
9.1 INTRODUCTION 233
9.1.1 APPROVAL AS A MAJOR GROWTH STRATEGY OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PLAYERS 234
9.2 APPROVAL 234
9.3 NEW PRODUCT LAUNCH 241
9.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES 245
9.5 OTHER DEVELOPMENTS 250
9.6 MERGERS and AQUSITIONS 253
9.7 BUSINESS EXPANSION 257
10 MAJOR PLAYER PROFILES 261
10.1 ABBOTT LABORATORIES 261
10.1.1 OVERVIEW 261
10.1.2 FINANCIALS 262
10.1.3 PRODUCT PORTFOLIO 265
10.1.4 KEY DEVELOPMENTS 266
10.1.5 BUSINESS STRATEGY 268
10.1.6 SWOT ANALYSIS 270
10.2 B. BRAUN MELSUNGEN AG 271
10.2.1 OVERVIEW 271
10.2.2 FINANCIALS 272
10.2.3 PRODUCT PORTFOLIO 274
10.2.4 KEY DEVELOPMENTS 275
10.2.5 BUSINESS STRATEGY 277
10.2.6 SWOT ANALYSIS 278
10.3 BIOSENSORS INTERNATIONAL GROUP 279
10.3.1 OVERVIEW 279
10.3.2 FINANCIALS 280
10.3.3 PRODUCT PORTFOLIO 282
10.3.4 KEY DEVELOPMENTS 283
10.3.5 BUSINESS STRATEGY 285
10.3.6 SWOT ANALYSIS 286
10.4 BIOTRONIK SE and CO. KG 287
10.4.1 OVERVIEW 287
10.4.2 FINANCIALS 287
10.4.3 PRODUCT PORTFOLIO 288
10.4.4 KEY DEVELOPMENTS 288
10.4.5 BUSINESS STRATEGY 289
10.4.6 SWOT ANALYSIS 290
10.5 BOSTON SCIENTIFIC CORPOARTION 291
10.5.1 OVERVIEW 291
10.5.2 FINANCIALS 292
10.5.3 PRODUCT PORTFOLIO 295
10.5.4 KEY DEVELOPMENTS 297
10.5.5 BUSINESS STRATEGY 298
10.5.6 SWOT ANALYSIS 299
10.6 C.R.BARD INC. 300
10.6.1 OVERVIEW 300
10.6.2 FINANCIALS 301
10.6.3 PRODUCT PORTFOLIO 302
10.6.4 KEY DEVELOPMENTS 304
10.6.5 BUSINESS STRATEGY 304
10.6.6 SWOT ANALYSIS 305
10.7 COOK MEDICAL INC 306
10.7.1 OVERVIEW 306
10.7.2 FINANCIALS 306
10.7.3 PRODUCT PORTFOLIO 306
10.7.4 KEY DEVELOPMENTS 307
10.7.5 BUSINESS STRATEGY 309
10.7.6 SWOT ANALYSIS 309
10.8 JOHNSON and JOHNSON (CORDIS CORPORATION) 310
10.8.1 OVERVIEW 310
10.8.2 FINANCIALS 311
10.8.3 PRODUCT PORTFOLIO 313
10.8.4 KEY DEVELOPMENTS 313
10.8.5 BUSINESS STRATEGY 314
10.8.6 SWOT ANALYSIS 315
10.9 MEDTRONIC INC 316
10.9.1 OVERVIEW 316
10.9.2 FINANCIALS 317
10.9.3 PRODUCT PORTFOLIO 319
10.9.4 KEY DEVELOPMENTS 320
10.9.5 BUSINESS STRATEGY 321
10.9.6 SWOT ANALYSIS 322
10.10 MICROPORT SCIENTIFIC CORPORATION 323
10.10.1 OVERVIEW 323
10.10.2 FINANCIALS 324
10.10.3 PRODUCT PORTFOLIO 326
10.10.4 KEY DEVELOPMENTS 327
10.10.5 BUSINESS STRATEGY 330
10.10.6 SWOT ANALYSIS 331
10.11 OLYMPUS CORPORATION 332
10.11.1 OVERVIEW 332
10.11.2 FINANCIALS 333
10.11.3 PRODUCT PORTFOLIO 335
10.11.4 KEY DEVELOPMENTS 336
10.11.5 BUSINESS STRATEGY 338
10.11.6 SWOT ANALYSIS 339
10.12 TERUMO CORPORATION 340
10.12.1 OVERVIEW 340
10.12.2 FINANCIALS 341
10.12.3 PRODUCT PORTFOLIO 344
10.12.4 KEY DEVELOPMENTS 344
10.12.5 BUSINESS STRATEGY 347
10.12.6 SWOT ANALYSIS 348

LIST OF TABLES

TABLE 1 GLOBAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 25
TABLE 2 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 26
TABLE 3 GLOBAL STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 26
TABLE 4 GLOBAL STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 27
TABLE 5 GLOBAL STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN) 28
TABLE 6 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 89
TABLE 7 GLOBAL STENTS PROCEDURAL VOLUME, BY TYPE, (2013-2021) (NO'S) 90
TABLE 8 GLOBAL BARE METAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 92
TABLE 9 GLOBAL BARE METAL STENTS PROCEDURAL VOLUME, BY REGION,
(2013-2021) (NO'S) 93
TABLE 10 GLOBAL DRUG ELUTING STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 95
TABLE 11 GLOBAL DRUG ELUTING STENTS PROCEDURAL VOLUME, BY REGION, (2013-2021) (NO'S) 95
TABLE 12 GLOBAL BIO-RESORBABLE STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 99
TABLE 13 GLOBAL BIO-RESORBABLE STENTS PROCEDURAL VOLUME, BY REGION, (2013-2021) (NO'S) 100
TABLE 14 GLOBAL OTHERS STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 101
TABLE 15 GLOBAL STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 104
TABLE 16 GLOBAL VASCULAR STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 106
TABLE 17 GLOBAL VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 106
TABLE 18 GLOBAL CORONARY STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 109
TABLE 19 GLOBAL PERIPHERAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 111
TABLE 20 GLOBAL PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 112
TABLE 21 GLOBAL LOWER EXTREMITY and ILIAC ARTERY STENTS MARKET REVENUE,
BY REGION, (2013-2021) ($MN) 114
TABLE 22 GLOBAL NEUROVASCULAR STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 115
TABLE 23 GLOBAL NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 116
TABLE 24 GLOBAL CAROTID STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 117
TABLE 25 GLOBAL INTRACRANIAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 119
TABLE 26 GLOBAL RENAL ARTERY STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 121
TABLE 27 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 124
TABLE 28 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 124
TABLE 29 GLOBAL GASTROINTESTINAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 126
TABLE 30 GLOBAL GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 127
TABLE 31 GLOBAL PANCREATIC and BILIARY STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 129
TABLE 32 GLOBAL ESOPHAGEAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 131
TABLE 33 GLOBAL COLORECTAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 132
TABLE 34 GLOBAL DUODENAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 133
TABLE 35 GLOBAL AIRWAY STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 135
TABLE 36 GLOBAL UROLOGY STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 136
TABLE 37 GLOBAL UROLOGY STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 137
TABLE 38 GLOBAL URETERAL and URETHRAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 139
TABLE 39 GLOBAL PROSTATE STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 141
TABLE 40 GLOBAL OPHTHALMOLOGY and OTHER STENTS MARKET REVENUE,
BY REGION, (2013-2021) ($MN) 143
TABLE 41 GLOBAL STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 146
TABLE 42 GLOBAL METAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 148
TABLE 43 GLOBAL METAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 149
TABLE 44 GLOBAL COBALT-CHROMIUM STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 150
TABLE 45 GLOBAL NICKEL-TITANIUM STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 152
TABLE 46 GLOBAL PLATINUM-CHROMIUM STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 153
TABLE 47 GLOBAL STAINLESS STEEL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 155
TABLE 48 GLOBAL OTHER METAL STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 156
TABLE 49 GLOBAL POLYMER STENTS MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 159
TABLE 50 GLOBAL POLYMER STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 159
TABLE 51 GLOBAL DURABLE POLYMER STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 161
TABLE 52 GLOBAL BIO-ABSORBABLE POLYMER STENTS MARKET REVENUE,
BY REGION, (2013-2021) ($MN) 163
TABLE 53 GLOBAL STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN) 166
TABLE 54 GLOBAL NON-COATED STENT MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 168
TABLE 55 GLOBAL COATED STENT MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 170
TABLE 56 GLOBAL COATED STENT MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 170
TABLE 57 GLOBAL INORGANIC COATED STENT MARKET REVENUE, BY REGION, (2013-2021) ($MN) 172
TABLE 58 GLOBAL POLYMER COATED STENT MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 173
TABLE 59 GLOBAL POLYMER COATED MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 174
TABLE 60 GLOBAL NON-BIODEGRADABLE POLYMER COATED STENT MARKET REVENUE, BY REGION, (2013-2021) ($MN) 177
TABLE 61 GLOBAL BIO-DEGRADABLE POLYMER COATED STENT MARKET REVENUE,
BY REGION, (2013-2021) ($MN) 179
TABLE 62 GLOBAL POLYMER-FREE COATED STENT MARKET REVENUE, BY REGION, (2013-2021) ($MN) 181
TABLE 63 GLOBAL OTHER COATED STENT MARKET REVENUE, BY REGION,
(2013-2021) ($MN) 183
TABLE 64 NORTH AMERICAN STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 188
TABLE 65 NORTH AMERICAN STENTS MARKET REVENUE, BY APPLICATION,
(2013-2021) ($MN) 188
TABLE 66 NORTH AMERICAN VASCULAR STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 189
TABLE 67 NORTH AMERICAN PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 190
TABLE 68 NORTH AMERICAN NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 190
TABLE 69 NORTH AMERICAN NON-VASCULAR STENTS MARKET REVENUE,
BY SEGMENT, (2013-2021) ($MN) 191
TABLE 70 NORTH AMERICAN GASTROINTESTINAL STENTS MARKET REVENUE,
BY TYPE, (2013-2021) ($MN) 192
TABLE 71 NORTH AMERICAN UROLOGY STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 192
TABLE 72 NORTH AMERICAN STENT MARKET REVENUE, BY MATERIAL TYPE,
(2013-2021) ($MN) 193
TABLE 73 NORTH AMERICAN METAL STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 194
TABLE 74 NORTH AMERICAN POLYMER STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 194
TABLE 75 NORTH AMERICAN STENT MARKET REVENUE, BY COATING TYPE,
(2013-2021) ($MN) 195
TABLE 76 NORTH AMERICAN STENT COATED MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 196
TABLE 77 NORTH AMERICAN POLYMER COATED MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 196
TABLE 78 EUROPEAN STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 199
TABLE 79 EUROPEAN STENTS MARKET REVENUE, BY APPLICATION,
(2013-2021) ($MN) 199
TABLE 80 EUROPEAN VASCULAR STENTS MARKET REVENUE BY SEGMENT,
(2013-2021) ($MN) 200
TABLE 81 EUROPEAN PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 201
TABLE 82 EUROPEAN NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 201
TABLE 83 EUROPEAN NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 202
TABLE 84 EUROPEAN GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 203
TABLE 85 EUROPEAN UROLOGY STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 203
TABLE 86 EUROPEAN STENT MARKET REVENUE, BY MATERIAL TYPE,
(2013-2021) ($MN) 204
TABLE 87 EUROPEAN METAL STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 205
TABLE 88 EUROPEAN POLYMER STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 205
TABLE 89 EUROPEAN STENT MARKET REVENUE, BY COATING TYPE,
(2013-2021) ($MN) 206
TABLE 90 EUROPEAN STENT COATED MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 207
TABLE 91 EUROPEAN POLYMER COATED MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 207
TABLE 92 ASIA-PACIFIC STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 211
TABLE 93 ASIA-PACIFIC STENTS MARKET REVENUE, BY APPLICATION,
(2013-2021) ($MN) 211
TABLE 94 ASIA-PACIFIC VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 212
TABLE 95 ASIA-PACIFIC PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 213
TABLE 96 ASIA-PACIFIC NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 213
TABLE 97 ASIA-PACIFIC NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 214
TABLE 98 ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 215
TABLE 99 ASIA-PACIFIC UROLOGY STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 215
TABLE 100 ASIA-PACIFIC STENT MARKET REVENUE, BY MATERIAL TYPE,
(2013-2021) ($MN) 216
TABLE 101 ASIA-PACIFIC METAL STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 217
TABLE 102 ASIA-PACIFIC POLYMER STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 217
TABLE 103 ASIA-PACIFIC STENT MARKET REVENUE, BY COATING TYPE,
(2013-2021) ($MN) 218
TABLE 104 ASIA-PACIFIC COATED STENT MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 219
TABLE 105 ASIA-PACIFIC POLYMER COATED MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 219
TABLE 106 ROW STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 223
TABLE 107 ROW STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 223
TABLE 108 ROW VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 224
TABLE 109 ROW PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 225
TABLE 110 ROW NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 225
TABLE 111 ROW NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2013-2021) ($MN) 226
TABLE 112 ROW GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE,
(2013-2021) ($MN) 227
TABLE 113 ROW UROLOGY STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 227
TABLE 114 ROW STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 228
TABLE 115 ROW METAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 229
TABLE 116 ROW POLYMER STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 229
TABLE 117 ROW STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN)MN) 230
TABLE 118 ROW COATED STENT MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 231
TABLE 119 ROW POLYMER COATED MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 231
TABLE 120 APPROVAL (2013-2015) 235
TABLE 121 NEW PRODUCTS LAUNCH (2013-2015) 241
TABLE 122 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS and JOINT VENTURES (2013-2015) 246
TABLE 123 OTHER DEVELOPMENTS (2013-2015) 250
TABLE 124 MERGERS and ACQUISITION (2013-2015) 254
TABLE 125 BUSINESS EXPANSION (2013-2015) 257
TABLE 126 ABBOTT LABORATORIES: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 262
TABLE 127 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS,
(2012-2014) ($MN) 263
TABLE 128 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY,
(2012-2014) ($MN) 264
TABLE 129 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 272
TABLE 130 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENTS,
(2012-2014) ($MN) 273
TABLE 131 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 274
TABLE 132 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 280
TABLE 133 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 281
TABLE 134 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 282
TABLE 135 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 292
TABLE 136 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENT, (2012-14) ($MN) 293
TABLE 137 BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR BUSINESS REVENUE, BY SEGMNET, (2012-2014) ($MN) 294
TABLE 138 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 294
TABLE 139 C.R.BARD INC: TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 301
TABLE 140 C.R.BARD INC: TOTAL REVENUE, BY SEGMENT, (2012-14) ($MN) 302
TABLE 141 JOHNSON and JOHNSON: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 311
TABLE 142 JOHNSON and JOHNSON: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 312
TABLE 143 JOHNSON and JOHNSON: TOTAL REVENUE, BY GEOGRAPHY,
(2012-2014) ($MN) 312
TABLE 144 MEDTRONIC INC.: TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 317
TABLE 145 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 318
TABLE 146 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 318
TABLE 147 MICROPORT SCIENTIFIC CORPORATION : TOTAL REVENUE AND RandD EXPENSES, (2012-2014) ($MN) 324
TABLE 148 MICROPORT SCIENTIFIC CORPORATION:TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 325
TABLE 149 MICROPORT SCIENTIFIC CORPORATION : TOTAL REVENUE,
BY GEOGRAPHY, (2012-2014) ($MN) 326
TABLE 150 OLYMPUS CORPORATION : TOTAL REVENUE AND RandD EXPENSES,
(2012-2014) ($MN) 333
TABLE 151 OLYMPUS CORPORATION : TOTAL REVENUE, BY SEGMENT,
(2012-2014) ($MN) 334
TABLE 152 OLYMPUS CORPORATION : TOTAL REVENUE, BY REGION,
(2012-2014) ($MN) 335
TABLE 153 TERUMO CORPORATION: TOTAL REVENUE AND RandD EXPENSES,
(2011-2013) ($MN) 341
TABLE 154 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENT, (2011-13) ($MN) 342
TABLE 155 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,
(2011-2013) ($MN) 343


LIST OF FIGURES

FIGURE 1 GLOBAL STENTS MARKET SHARE, BY GEOGRAPHY, (2013-2021) ($MN) 24
FIGURE 2 RESEARCH METHODOLOGY: STENTS MARKET 34
FIGURE 3 STENTS MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 35
FIGURE 4 STENTS MARKET: FORECASTING MODEL 36
FIGURE 5 STENTS MARKET: MARKET CRACHDOWN AND DATA TRIANGULATION 37
FIGURE 6 STENTS MARKET: MARKET SEGMENTATION 43
FIGURE 7 MARKET DYNAMICS 46
FIGURE 8 STENTS MARKET: PORTER'S ANALYSIS 55
FIGURE 9 GLOBAL STENTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 60
FIGURE 10 STENTS DEVICES MARKET: SUPPLY CHAIN ANALYSIS 84
FIGURE 11 STENTS MARKET:PATENT FILING BY MAJOR PLAYERS, (2010-2015) 85
FIGURE 12 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2014 V'S 2021) ($MN) 88
FIGURE 13 GLOBAL STENTS MARKET REVENUE, BY APPLICATION,
(2013 - 2021) ($MN) 103
FIGURE 14 GLOBAL VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2014 V'S 2021) ($MN) 105
FIGURE 15 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,
(2014 V'S 2021) ($MN) 123
FIGURE 16 GLOBAL STENTS MARKET REVENUE, BY MATERIAL, (2014 V'S 2021) ($MN) 145
FIGURE 17 GLOBAL METAL STENTS MARKET REVENUE, BY TYPE, (2014 V'S 2021) ($MN) 147
FIGURE 18 GLOBAL POLYMER STENTS MARKET REVENUE, BY TYPE,
(2014 V'S 2021) ($MN) 158
FIGURE 19 GLOBAL STENTS MARKET REVENUE, BY COATING, (2014 V'S 2021) ($MN) 165
FIGURE 20 GLOBAL COATED STENTS MARKET REVENUE, BY TYPE,
(2014 V'S 2021) ($MN) 169
FIGURE 21 GLOBAL STENTS MARKET REVENUE, BY REGION, (2013- 2021) ($MN) 185
FIGURE 22 NORTH AMERICAN STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS and COATINGS, (2014 V'S 2021) ($MN) 187
FIGURE 23 EUROPEAN STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS and COATINGS, (2014 V'S 2021) ($MN) 198
FIGURE 24 ASIA-PACIFIC STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS and COATINGS, (2014 V'S 2021) ($MN) 210
FIGURE 25 ROW STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS and COATINGS, (2014 V'S 2021) ($MN) 222
FIGURE 26 KEY GROWTH STRATEGIES (2013-2015) 233
FIGURE 27 SWOT ANALYSIS: ABBOTT LABORATORIES 270
FIGURE 28 SWOT ANALYSIS: B.BRAUN MELSUNGEN AG 278
FIGURE 29 SWOT ANALYSIS: BIOSENSORS INTERNATIONAL GROUP 286
FIGURE 30 SWOT ANALYSIS: BIOTRONIK SE and CO. KG 290
FIGURE 31 SWOT ANALYSIS: BOSTON SCIENTIFIC CORPORATION 299
FIGURE 32 SWOT ANALYSIS: C.R.BARD INC. 305
FIGURE 33 SWOT ANALYSIS: COOK MEDICAL INC. 309
FIGURE 34 SWOT ANALYSIS: JOHNSON and JOHNSON 315
FIGURE 35 SWOT ANALYSIS: MEDTRONIC INC 322
FIGURE 36 SWOT ANALYSIS: MICROPORT SCIENTIFIC CORPORATION 331
FIGURE 37 SWOT ANALYSIS: OLYMPUS CORPORATION 339
FIGURE 38 SWOT ANALYSIS: TERUMO CORPORATION 348

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
European Market Report for Dialysis Catheters 2017 - MedCore

European Market Report for Dialysis Catheters 2017 - MedCore

  • $ 6495
  • Industry report
  • November 2016
  • by iData Research, Inc.

Description The European market for dialysis catheters comprises the acute hemodialysis, chronic hemodialysis and peritoneal dialysis catheter segments. The chronic hemodialysis catheter market is segmented ...

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Vascular Access Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

Vascular Access Devices Market: Scope and Methodology Vascular access devices are medical devices used to obtain access to the bloodstream, and are hollow and flexible tubes made of latex, silicone, and ...

Czech Republic Interventional Cardiology Market Outlook to 2022

Czech Republic Interventional Cardiology Market Outlook to 2022

  • $ 4995
  • Industry report
  • September 2016
  • by Global Data

Czech Republic Interventional Cardiology Market Outlook to 2022 Summary GlobalData’s new report, Czech Republic Interventional Cardiology Market Outlook to 2022, provides key market data on the Czech ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.